foxo4-dri senolytic 2023 2024 Peptide Inhibitors Targeting FOXO4-p53 Interactions and Inducing Senescent Cancer Cell-specific Apoptosis Immunofluorescence reveals the effect of
Immunofluorescence reveals the effect of FOXO4 D Retro Inverso on p53 Download Scientific Diagram Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients' treatment npj Aging The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Senolytic Drugs Market to Reach USD 667.6 Million by 2033 Cellular Senescence in Health, Disease, and Lens Aging CHK2 USP37 axis stabilizes FOXO4 to sustain senescence and evade apoptosis PNAS
Pay in 4 interest-free payments of $6.21 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6





